HADHs as modifiers of the p21 pathway and methods of use

Details HADHs as modifiers of the p21 pathway and methods of use HADHs as modifiers of the p21 pathway and methods of use

2005-08-09

2005-08-09

Canella, Karen A. (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C436S501000

Reexamination Certificate

active

06927022

ABSTRACT:
Human HADH genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of HADH are provided.

REFERENCES:
patent: 5235033 (1993-08-01), Summerton et al.
patent: 5518911 (1996-05-01), Abo et al.
patent: WO 01/64840 (2001-09-01), None
Abstract of Charreau et al (Transgene Research, 1996, vol. 5, pp. 223-234).
Abstract of Nancarrow et al (Methods in molecular biology, 1993, vol. 18, pp. 273-303).
Abstract of Machaty et al (Cloning Stem Cells, 202, vol. 4, pp. 21-27).
Abstract of Hudziak et al (Antisense Nucleic Acid Drug Dev, Jun. 2000, vol. 10, pp. 163-176).
Brenner et al (PNAS, 1998, Volt, 95, pp. 6073-6078).
Bork, Genome Research, 2000, vol. 10, pp. 398-400.
Brock, Biology of Microorganisms (textbook), 1979, p. 64.
Bork and Koonin (Nature Genetics, 1998, vol. 18, pp. 313-318).
Huynen and Bork, PNAS, 1998, vol. 95, pp. 5849-5856.
Huynen et al, Genome Research, 2000, vol. 10, pp. 1204-1210.
Smith,M., “Human DNA sequence from clone RP4-694B14 on chromosome 20p11.1-11.22 Contains a novel KRAB box protein with 18 C2H2 type zinc finger domains, a novel haloacid dehalogenase-like hydrolase family protein similar to (archaea) bacterial proteins, two putative novel genes, a novel pseudogene, ESTs, an STS, GSSs and three CpG islands, complete sequence.” Genbank GI No. 11968366, Apr. 4, 2001.
Strausberg,R., “Homo sapiens, Similar to Riken cDNA 1600031M04 gene, clone MGC:26833 Image:4819016, mRNA, complete cds.” Genbank GI No. 18490373, Feb. 04, 2002.
Strausberg, R., “Cloned unidirectionally; oligo-dT primed. Average insert size 2.5 kb. Library enriched for full-length clones and constructed by Life Technologies. Note: this is a NIH_MGCLibrary.” Genbank GI No. 20405373, May 1, 2002.

Affiliated with

Also associated with

Rating

HADHs as modifiers of the p21 pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HADHs as modifiers of the p21 pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HADHs as modifiers of the p21 pathway and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3522454